|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 141.7 EUR | -4.90% |
|
-6.31% | -10.06% |
| Apr. 24 | IMCD's Spanish Unit to Buy Cobapharma | MT |
| Mar. 27 | IMCD's Benelux Arm to Purchase Gova Ingredients | MT |
IMCD N.V. (ENXTAM:IMCD) signed an agreement to acquire ResChem Technologies Pty Ltd. on February 16, 2024. For FY 2023, ResChem generated a revenue of approximately AUD 25 million with 15 employees and strengthens IMCD's technical expertise with an application laboratory based in Sydney. The closing of the transaction is subject to customary closing conditions and is expected to take place in the second quarter of 2024.
Adam Salter of Jones Day acted as legal advisor to IMCD N.V.
| 1st Jan change | Capi. | |
|---|---|---|
| -10.06% | 8.61B | |
| +25.96% | 1.01B | |
| +8.23% | 173M | |
| +36.99% | 143M | |
| +4.24% | 115M | |
| -4.88% | 99.64M | |
| +7.15% | 87.9M |
IMCD N.V. 
